Hospital‐Level Variation in Ticagrelor Use in Patients With Acute Coronary Syndrome

BACKGROUND: Despite improved outcomes associated with ticagrelor compared with clopidogrel in acute coronary syndrome (ACS), many studies have demonstrated slow adoption of ticagrelor in the United States because of its increased cost. Less is known about how ticagrelor is adopted when there is no a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozaki, Aya F., Jackevicius, Cynthia A., Chong, Alice, Sud, Maneesh, Fang, Jiming, Austin, Peter C., Ko, Dennis T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333376/
https://www.ncbi.nlm.nih.gov/pubmed/35766263
http://dx.doi.org/10.1161/JAHA.121.024835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333376/
https://www.ncbi.nlm.nih.gov/pubmed/35766263
http://dx.doi.org/10.1161/JAHA.121.024835

Ejemplares similares